| |
| |
| Historical Perspective of Medicinal Chemistry | |
| |
| |
| |
| Principles of Drug Discovery | |
| |
| |
| |
| Drug Discovery from Natural Products | |
| |
| |
| |
| Drug Design and Relationship of Functional Groups to Pharmacologic Activity | |
| |
| |
| |
| Molecular Modeling and in Silico | |
| |
| |
| |
| Receptors and Drug Action | |
| |
| |
| |
| Drug Discovery Through Enzyme Inhibition | |
| |
| |
| |
| Pharmaceutical Biotechnology-From Nucleic Acids to Personalized Medicine | |
| |
| |
| |
| Peptide and Protein Drugs | |
| |
| |
| |
| Antisense Therapeutic Agents | |
| |
| |
| |
| Physicochemical and Biopharmaceutical Properties of Drug Substances and Pharmacokinetics | |
| |
| |
| |
| Drug Metabolism | |
| |
| |
| |
| Drug Regulation: An Overview | |
| |
| |
| |
| Drug Receptors Affecting Neurotransmission and Enzymes as Catalytic Receptors | |
| |
| |
| Overview of Drug Receptors: A Perspective | |
| |
| |
| |
| Drugs Affecting Cholinergic Neurotransmission | |
| |
| |
| |
| Adrenergic Receptors and Drugs Affecting Adrenergic Neurotransmission | |
| |
| |
| |
| Serotonin Receptors and Drugs Affecting Serotonergic Neurotransmission | |
| |
| |
| |
| Amino Acid Neurotransmitters in the Central Nervous System | |
| |
| |
| |
| Inhibitors of Nerve Conduction: Local Anesthetics | |
| |
| |
| |
| Phosphodiesterase Inhibitors | |
| |
| |
| |
| Pharmacodynamic Agents | |
| |
| |
| |
| Drugs Affecting Central Nervous System | |
| |
| |
| |
| General Anesthetics | |
| |
| |
| |
| Sedative-Hypnotics | |
| |
| |
| |
| Antiseizure Agents | |
| |
| |
| |
| Antidepressants | |
| |
| |
| |
| Psychotherapeutic Drugs: Antipsychotic and Anxiolytic Agents | |
| |
| |
| |
| Hallucinogens, Stimulants and Related Drugs of Abuse | |
| |
| |
| |
| Opioid Analgesics | |
| |
| |
| |
| Drugs Used to Treat Neuromuscular Disorders: Antiparkinsonian and Spasmolytic Agents | |
| |
| |
| |
| Drugs Affecting the Cardiovascular System | |
| |
| |
| |
| Cardiac Agents: Cardiac Glycosides, Antianginal, and Antiarrhythmic Drugs | |
| |
| |
| |
| Diuretics | |
| |
| |
| |
| Angiotensin Converting Enzyme Inhibitors, Antagonists and Calcium Blockers | |
| |
| |
| |
| Central and Peripheral Sympatholytics and Vasodilators | |
| |
| |
| |
| Antihyperlipoproteinemics and Inhibitors of Cholesterol Biosynthesis | |
| |
| |
| |
| Antithrombotics, Thrombolytics, Coagulants, and Plasma Extenders | |
| |
| |
| |
| Drugs Affecting the Hormonal Systems | |
| |
| |
| |
| Insulin and Drugs Used for the Treatment of Diabetes | |
| |
| |
| |
| Adrenocorticoids | |
| |
| |
| |
| Thyroid Function and Thyroid Drugs | |
| |
| |
| |
| Calcium Homeostasis | |
| |
| |
| |
| Drugs Affecting the Immune Systems | |
| |
| |
| |
| Nonsteroidal Anti-Inflammatory Drugs | |
| |
| |
| |
| Antihistamines and Related Antiallergic and Antiulcer Agents | |
| |
| |
| |
| Chemotherapeutic Agents | |
| |
| |
| |
| Antibiotics and Antimicrobial Agents | |
| |
| |
| |
| Antiparasitic Agents | |
| |
| |
| |
| Antifungal Agents | |
| |
| |
| |
| Antimycobacterial Agents | |
| |
| |
| |
| Cancer and Chemotherapy | |
| |
| |
| |
| Antiviral Agents and Protease Inhibitors | |
| |
| |
| |
| Disease State Management | |
| |
| |
| |
| Asthma and Chronic Obstructive Pulmonary Disease | |
| |
| |
| |
| Men' Health | |
| |
| |
| |
| Women's Health | |
| |
| |
| |
| pKa Values for Some Drugs and Miscellaneous Organic Acids and Bases | |
| |
| |
| |
| pH Values for Tissue Fluids | |